Inventor · disambiguated record
Tsugumine Shu
Also filed as: SHU TSUGUMINE
4 granted patents·14 pending applications·16 citations·filing 2001–2021
63Inventor score
Files withI PEACE INC2INOUE MAKOTO2JAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES2DNAVEC CORP1DNAVEC RESEARCH INC1
Top patents by PatentIndex Score
18 records- 0181US7226786B2Envelope gene-deficient Paramyxovirus vectorDNAVEC RESEARCH INC·Filed 2002·Granted Jun 5, 2007·16 cites·16 claims
- 0259US2012087940A1Vector for treating alzheimer's diseaseINOUE MAKOTO·Filed 2009·Application pending·0 cites
- 0354US2021177909A1Supernatant of brown adipocytes, method for preparing same and utilization thereofNAT CENTER FOR GLOBAL HEALTH AND MEDICINE·Filed 2019·Application pending·0 cites
- 0448US2023220025A1Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS CellsHEARTSEED INC·Filed 2021·Application pending·0 cites
- 0548US2003166252A1Paramyxovirus-derived RNPFiled 2002·Application pending·0 cites
- 0648US2012088819A1Method for enhancing expression of recombinant proteinINOUE MAKOTO·Filed 2009·Application pending·0 cites
- 0747US2007009949A1Paramyxovirus-derived RNPKITAZATO KAIO·Filed 2006·Application pending·0 cites
- 0847US2024060051A1Method for Producing Naive Human IPS Cells From Somatic CellsUNIV KYOTO·Filed 2021·Application pending·0 cites
- 0944US2022169990A1Method for producing cardiomyocyteI PEACE INC·Filed 2020·Application pending·0 cites
- 1042US2020392455A1Nerve cell production methodI PEACE INC·Filed 2018·Application pending·0 cites
- 1141US2010167341A1Novel protein expression systemDNAVEC CORP·Filed 2007·Application pending·0 cites
- 1241US2011162093A1Methods for producing antibodiesUEDA YASUJI·Filed 2006·Application pending·0 cites
- 1339US11103574B2Infectious disease vaccine using non-infectious paramyxovirus particleJAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2017·Granted Aug 31, 2021·0 cites·13 claims
- 1439US2003022376A1Paramyxovirus-derived RNPFiled 2001·Application pending·0 cites
- 1539US2002169306A1Envelope gene-deficient paramyxovirus vectorFiled 2001·Application pending·0 cites
- 1635US10828359B2Anti-Mycobacterium tuberculosis vaccine using sendai virus as vectorSHANGHAI PUBLIC HEALTH CLINICAL CENTER FUDAN UNIV·Filed 2016·Granted Nov 10, 2020·0 cites·17 claims
- 1735US2020353070A1Selective cd8-positive t cell-inducing vaccine antigenJAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES·Filed 2019·Application pending·0 cites
- 1831US12215334B2Polynucleotide for modifying target sequence and use thereofIROM GROUP CO LTD·Filed 2018·Granted Feb 4, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Tsugumine Shu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →